EE03135B1 - Transdermaalne terapeutiline süsteem füsostigmiini manustamiseks ja meetod selle valmistamiseks - Google Patents

Transdermaalne terapeutiline süsteem füsostigmiini manustamiseks ja meetod selle valmistamiseks

Info

Publication number
EE03135B1
EE03135B1 EE9400145A EE9400145A EE03135B1 EE 03135 B1 EE03135 B1 EE 03135B1 EE 9400145 A EE9400145 A EE 9400145A EE 9400145 A EE9400145 A EE 9400145A EE 03135 B1 EE03135 B1 EE 03135B1
Authority
EE
Estonia
Prior art keywords
pct
physostigmine
administration
therapeutic system
transdermal therapeutic
Prior art date
Application number
EE9400145A
Other languages
English (en)
Estonian (et)
Inventor
Deurer Lothar
Hille Thomas
Profitlich Thomas
Stanislaus Fritz
Walter Kersten
Original Assignee
Klinge Pharma Gmbh
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Pharma Gmbh, Lts Lohmann Therapie-Systeme Gmbh & Co. Kg filed Critical Klinge Pharma Gmbh
Publication of EE03135B1 publication Critical patent/EE03135B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
EE9400145A 1992-11-12 1994-11-18 Transdermaalne terapeutiline süsteem füsostigmiini manustamiseks ja meetod selle valmistamiseks EE03135B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238223A DE4238223C1 (de) 1992-11-12 1992-11-12 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung

Publications (1)

Publication Number Publication Date
EE03135B1 true EE03135B1 (et) 1998-12-15

Family

ID=6472735

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400145A EE03135B1 (et) 1992-11-12 1994-11-18 Transdermaalne terapeutiline süsteem füsostigmiini manustamiseks ja meetod selle valmistamiseks

Country Status (32)

Country Link
US (1) US5698216A (xx)
EP (1) EP0667774B1 (xx)
JP (1) JP3407073B2 (xx)
KR (1) KR100254573B1 (xx)
CN (1) CN1088457A (xx)
AT (1) ATE156356T1 (xx)
AU (1) AU684256B2 (xx)
CA (1) CA2147274C (xx)
CZ (1) CZ284008B6 (xx)
DE (2) DE4238223C1 (xx)
DK (1) DK0667774T3 (xx)
EE (1) EE03135B1 (xx)
EG (1) EG20527A (xx)
ES (1) ES2105334T3 (xx)
FI (1) FI952269A0 (xx)
GR (1) GR3024720T3 (xx)
HR (1) HRP931391B1 (xx)
HU (1) HUT72963A (xx)
IL (1) IL107547A (xx)
LT (1) LT3107B (xx)
LV (1) LV10749B (xx)
MD (1) MD937C2 (xx)
MY (1) MY111373A (xx)
NO (1) NO306760B1 (xx)
NZ (1) NZ257136A (xx)
PL (1) PL172999B1 (xx)
RU (1) RU2108812C1 (xx)
SI (1) SI9300589A (xx)
SK (1) SK280185B6 (xx)
WO (1) WO1994010999A1 (xx)
YU (1) YU71293A (xx)
ZA (1) ZA938413B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
AT500143A1 (de) * 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
IL72684A (en) 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
DE3843239C1 (xx) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843238C1 (xx) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
JP4355469B2 (ja) * 2002-03-08 2009-11-04 日本碍子株式会社 アルミナ担持担体、触媒体及びアルミナ担持担体の製造方法

Also Published As

Publication number Publication date
IL107547A0 (en) 1994-02-27
SI9300589A (en) 1994-06-30
IL107547A (en) 1996-12-05
CZ284008B6 (cs) 1998-07-15
YU71293A (sh) 1996-07-24
DK0667774T3 (da) 1998-03-23
FI952269A (fi) 1995-05-10
HRP931391A2 (en) 1995-02-28
HUT72963A (en) 1996-06-28
NO951864D0 (no) 1995-05-11
EP0667774B1 (de) 1997-08-06
MD937C2 (ro) 1999-01-31
SK59395A3 (en) 1996-05-08
NO951864L (no) 1995-05-11
NZ257136A (en) 1996-07-26
CA2147274A1 (en) 1994-05-26
CA2147274C (en) 2005-12-13
HU9501390D0 (en) 1995-06-28
DE59307089D1 (de) 1997-09-11
SK280185B6 (sk) 1999-09-10
JP3407073B2 (ja) 2003-05-19
AU684256B2 (en) 1997-12-11
MY111373A (en) 1999-12-31
LT3107B (en) 1994-12-27
MD940311A (en) 1998-03-31
PL172999B1 (pl) 1998-01-30
EG20527A (en) 1999-06-30
RU2108812C1 (ru) 1998-04-20
LV10749A (lv) 1995-08-20
WO1994010999A1 (de) 1994-05-26
FI952269A0 (fi) 1995-05-10
KR950703948A (ko) 1995-11-17
ES2105334T3 (es) 1997-10-16
EP0667774A1 (de) 1995-08-23
LV10749B (en) 1996-06-20
MD937B2 (xx) 1998-03-31
CN1088457A (zh) 1994-06-29
KR100254573B1 (ko) 2000-05-01
GR3024720T3 (en) 1997-12-31
NO306760B1 (no) 1999-12-20
PL308531A1 (en) 1995-08-21
AU5338594A (en) 1994-06-08
US5698216A (en) 1997-12-16
HRP931391B1 (en) 1999-12-31
ATE156356T1 (de) 1997-08-15
DE4238223C1 (de) 1994-05-26
CZ124495A3 (en) 1996-01-17
JPH08502986A (ja) 1996-04-02
ZA938413B (en) 1994-06-09
LTIP1469A (en) 1994-06-15

Similar Documents

Publication Publication Date Title
AU679032B2 (en) Transdermal therapeutic system with galanthamine as active ingredient
PL307786A1 (en) Plaster for percutaneous administration of systemically acting steroid hormones
EE03135B1 (et) Transdermaalne terapeutiline süsteem füsostigmiini manustamiseks ja meetod selle valmistamiseks